Literature DB >> 1755931

Concentration-related effects of morphine on cognition and motor control in human subjects.

B Kerr1, H Hill, B Coda, M Calogero, C R Chapman, E Hunt, V Buffington, A Mackie.   

Abstract

Morphine and other opioid analgesics may interfere with normal cognition and motor function when the drugs are used for long-term treatment of pain. We used individually tailored steady-state drug infusions to identify the nature and extent of cognitive and motor effects of the mu-receptor-selective opioid morphine in healthy volunteers. The tailored infusions allowed evaluation of cognitive and motor effects at three sequential, constant plasma concentrations of morphine in each subject. Compared with functional assessments obtained in a separate saline infusion day, infusions of morphine to plasma concentrations in the usual therapeutic range for analgesia caused significant impairments of some but not all elements of cognitive and motor function. The time needed to encode and process serially presented verbal information increased and the ability to maintain low consistent levels of force decreased during the morphine infusion. We also assessed verbal recall 3 hours after the morphine and saline infusions. Delayed recall of information presented during the morphine infusion was significantly impaired. Our results demonstrate that morphine can interfere with cognitive and motor performance at plasma drug concentrations within the usual therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755931

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  20 in total

1.  Self-organized synaptic plasticity contributes to the shaping of gamma and beta oscillations in vitro.

Authors:  A Bibbig; H J Faulkner; M A Whittington; R D Traub
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  The effects of acute and chronic steady state methadone on memory retrieval in rats.

Authors:  Erin Cummins; Craig P Allen; Alexander Ricchetti; Emily Boughner; Kayla Christenson; Megan Haines; Cheryl L Limebeer; Linda A Parker; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2012-01-19       Impact factor: 4.530

Review 3.  Neuropsychological consequences of opiate use.

Authors:  Staci A Gruber; Marisa M Silveri; Deborah A Yurgelun-Todd
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

4.  Does preoperative risk for delirium moderate the effects of postoperative pain and opiate use on postoperative delirium?

Authors:  Jacqueline M Leung; Laura P Sands; Eunjung Lim; Tiffany L Tsai; Sakura Kinjo
Journal:  Am J Geriatr Psychiatry       Date:  2013-05-06       Impact factor: 4.105

5.  Integrating pain management in clinical practice.

Authors:  Robert N Jamison; Robert R Edwards
Journal:  J Clin Psychol Med Settings       Date:  2012-03

Review 6.  A risk-benefit analysis of methadone maintenance treatment.

Authors:  J Bell; D Zador
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

7.  The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects.

Authors:  G W Hanks; W M O'Neill; P Simpson; K Wesnes
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Codeine and clinical impairment in samples in which morphine is not detected.

Authors:  Liliana Bachs; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-03-01       Impact factor: 2.953

9.  Does postoperative delirium limit the use of patient-controlled analgesia in older surgical patients?

Authors:  Jacqueline M Leung; Laura P Sands; Sudeshna Paul; Tim Joseph; Sakura Kinjo; Tiffany Tsai
Journal:  Anesthesiology       Date:  2009-09       Impact factor: 7.892

10.  Acute effects of opioids on memory functions of healthy men and women.

Authors:  James Friswell; Caroline Phillips; James Holding; Celia J A Morgan; Brigitta Brandner; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2008-04-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.